Norges Bank Invests $75.07 Million in HealthEquity, Inc. $HQY

Norges Bank acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 716,613 shares of the company’s stock, valued at approximately $75,072,000.

Several other large investors have also added to or reduced their stakes in HQY. Invesco Ltd. increased its holdings in HealthEquity by 50.6% in the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock worth $216,171,000 after purchasing an additional 821,425 shares in the last quarter. Westfield Capital Management Co. LP grew its position in shares of HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after buying an additional 701,819 shares during the period. Nuveen LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at $53,076,000. Price T Rowe Associates Inc. MD lifted its position in shares of HealthEquity by 995.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after acquiring an additional 580,988 shares during the period. Finally, Ameriprise Financial Inc. lifted its position in shares of HealthEquity by 148.1% during the 1st quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock valued at $59,203,000 after acquiring an additional 399,897 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Down 3.0%

HQY opened at $95.67 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The firm has a market capitalization of $8.24 billion, a PE ratio of 43.89, a P/E/G ratio of 1.42 and a beta of 0.18. The company’s 50-day moving average is $96.41 and its 200 day moving average is $96.87.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The business had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a return on equity of 12.95% and a net margin of 14.86%.The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling at HealthEquity

In related news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president owned 75,479 shares in the company, valued at approximately $7,892,084.24. This represents a 1.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 10,781 shares of company stock valued at $1,016,707 in the last quarter. 1.50% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Royal Bank Of Canada raised their price target on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, September 3rd. JMP Securities set a $122.00 target price on HealthEquity in a research note on Thursday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Finally, Citizens Jmp boosted their price objective on HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, HealthEquity has an average rating of “Moderate Buy” and an average price target of $120.07.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.